
Please try another search
The Dow jumped above 29,000 for the first time since February on Sep 2 and came within 500 points of its all-time record level. Last week, the index turned positive for 2020. For the year, the index is now up about 1.97% versus 10.84% gains in the S&P 500 and a jump of 34.4% in the Nasdaq. It looks like September is going to bode well for the blue-chip index Dow Jones. Let’s tell you why.
On Aug 27, the Federal Reserve announced a new strategy to bring back the United States to full employment level and drive inflation back to healthier levels. Under the new scheme, the U.S. central bank will seek to achieve inflation averaging 2% over time, counterbalancing below-2% periods with higher inflation "for some time."
The change in the Fed’s tone suggests the its key overnight interest rate, already at rock-bottom levels, will remain so in the medium term as the central bank is striving to drive inflation. Since a low-rate environment is great for stocks, Dow Jones rallied (read: Fed Targets "Average Inflation" of 2%: ETF Strategies to Play).
A Bloomberg article indicated that the U.S. Centers for Disease Control and Prevention has told states to prepare for a COVID-19 vaccine that would be ready by Nov 1. CDC asked states to clear any kind of bottlenecks that would stop distribution sites from opening. The clinical date suggests that the federal government anticipates a vaccine will become available even before the presidential election on Nov 3.
While Moderna (NASDAQ:MRNA) MRNA seems to be the most prominent candidate in the vaccine race,AstraZeneca (NYSE:AZN) plc AZN recently announced the beginning of a late-stage study in the United States on its coronavirus vaccine candidate, AZD1222, which it is developing in partnership with Oxford University. So, bets over vaccine and reopening trades are gaining traction (read: Biotech ETFs to Shine Bright on Coronavirus Vaccine Progress).
A slew of upbeat economic datapoints also helped the Dow Jones rally. After clocking the highest reading since March 2019 in July, U.S. manufacturing activity accelerated to a nearly two-year high in August amid a surge in new orders (read: Global Manufacturing Rebounding: ETFs in Focus).
The Institute for Supply Management (ISM) said on Sep 1 that its index of national factory activity rose to a reading of 56.0 last month from 54.2 in July. That marked the highest level since November 2018 and three successive months of growth. Economists polled by Reuters had forecast that the index would rise to 54.5 in August. Since Dow Jones is greatly related to the industrial sector, the index has every reason to fare better in September.
Against the aforementioned backdrop, below we highlight a few stocks that helped the Dow Jones to hit 29,000 once again.
The Coca-Cola Company (NYSE:KO) KO): Weight in Dow Jones (1.16%), Stock Up 4.21% on Sep 3
Dow Inc. DOW: Weight in Dow Jones (1.11%), Stock Up 4.13% on Sep 3
International Business Machines (NYSE:IBM) Corp IBM: Weight in Dow Jones (2.90%), Stock Up 3.87% on Sep 3
Merck & Co Inc MRK: Weight in Dow Jones (1.97%), Stock Up 2.96% on Sep 3
Amgen Inc (NASDAQ:AMGN) (AMGN): Weight in Dow Jones (5.84%), Stock Up 2.89% on Sep 3
Investors seeking a momentum play can also watch out for SPDR Dow Jones Industrial Average (NYSE:DIA) ETF DIA with a Zacks Rank #3 (Hold), and Guggenheim Dow Jones Industrial Average Dividend ETF DJD) and iShares Dow Jones US ETF (IYY) with a Zacks Rank #2 (Buy) each.
Investors can also settle for leveraged Dow ETFs for as long as the trend favors them. Here, ProShares Ultra Dow30 (DDM) and ProShares UltraPro Dow30 (UDOW) are a couple of choices (see all leveraged equity ETFs here).
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
International Business Machines Corporation (IBM): Free Stock Analysis Report
AstraZeneca PLC (AZN): Free Stock Analysis Report
Merck Co., Inc. (MRK): Free Stock Analysis Report
Moderna, Inc. (MRNA): Free Stock Analysis Report
CocaCola Company The (KO): Free Stock Analysis Report
Amgen Inc. (AMGN): Free Stock Analysis Report
Dow Inc. (DOW): Free Stock Analysis Report
SPDR Dow Jones Industrial Average ETF (DIA): ETF Research Reports
Invesco Dow Jones Industrial Average Dividend ETF (DJD): ETF Research Reports
To read this article on Zacks.com click here.
Zacks Investment Research
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Two weeks ago, the rumor mill ramped up again about the potential restructuring of Intel Corporation (NASDAQ:INTC). The probing balloons centered around Taiwan Semiconductor...
More than a century ago, then-Representative William McKinley pursued an aggressive tariff strategy that sought to protect American industry and reduce reliance on foreign...
Early in 2025, value stocks emerged as a popular choice among investors seeking market-beating returns. However, factor-based investing strategies can be notoriously difficult to...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.